TargEDys SA is a Paris health company making probiotic and prebiotic microbiome products for gut and metabolic health.
Founded in 2011 and headquartered in Paris, France, TargEDys SA makes microbiome modulation products using probiotics and prebiotics for digestive health, weight management and metabolic support, sold to consumers, health professionals and retailers in Europe and North America. Sergueï Fetissov is the founder. Its Series A round on September 18, 2019 raised EUR 4.164 million, which is also its total raised, at a current valuation of EUR 15.769 million, across four deals.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in